q1 earnings per share $1.99.
qtrly ebit margin of 23.3%.
qtrly constant currency organic revenue increased 12%.
expect that higher material labor costs will continue to impact gross margin by approximately $20 million or more in second half of fiscal year.
compname reports q3 revenue of $10 million.
qtrly adjusted effective tax rate of 22% higher than last year.
qtrly gross margin increased 120 basis points to 46.2% as favorable productivity, pricing and acquisitions were somewhat offset by higher material and labor costs.
compname reports 10% growth in dental segment for q3 of 2021.
qtrly organic volume growth was driven by a 130 basis points increase in organic volume.
qtrly consolidated net sales of $220 million, up 65% from prior year.
qtrly capital expenditures of $133.4 million, while depreciation and amortization was $201.7 million.
qtrly cash was $383.5 million at december 31, 2020.
qtrly total cash settlement value was approximately $371.4 million.
compname reports q2 adjusted ebitda per share of $2.8.
compname reports q1 2021 results; record backlog of $311 million for legacy steris products.
qtrly capital equipment backlog of $98 million.
